• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX 35 DRUG-ELUTING STENT Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Information (3190)
Event Date 09/06/2018
Event Type  Injury  
Manufacturer Narrative
Common device name: niu stent, superficial femoral artery, drug-eluting.
 
Event Description
Kibrik 2019 ¿a real-world experience of drug eluting and non-drug eluting stents in lower extremity peripheral arterial disease¿ a retrospective review was performed on all in patient infrainguinal lower extremity endovascular procedures between (b)(6) 2014 and (b)(6) 2016, which involved stent implantation.Procedures involving the common femoral artery, superficial femoral artery, and above knee popliteal artery were included.Procedures involving iliac, below knee popliteal, tibial, peroneal, and pedal arteries were excluded.The type of stent, number of stents, length of each stent, and location of stent were recorded for each procedure.Data on each patients trans-atlantic inter society consensus ii class were collected.End-points included stent thrombosis, restenosis, re-intervention, and limb loss.Post-operative arterial duplexes were obtained every three months to determine stent patency during follow-up visits.In-stent stenosis was defined as >60% narrowing on arterial duplex.Thrombosis was defined as in-stent occlusion, and limb loss involved only major amputations in the treated extremity.Bivariate analysis and students two-sample t-test were used to analyze the data.Ibm-spss ¿ 22 was used for all analyses.This file was opened to capture re-intervention - 14.3% for des.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX 35 DRUG-ELUTING STENT
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
MDR Report Key11035903
MDR Text Key222336603
Report Number3005580113-2020-00466
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2020,12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date12/08/2020
Event Location Hospital
Date Report to Manufacturer12/17/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-